Concepts (318)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Community Health Centers | 12 | 2013 | 115 | 0.950 |
Why?
|
| Diabetes Mellitus | 13 | 2014 | 745 | 0.650 |
Why?
|
| Alcohol Drinking | 3 | 2009 | 274 | 0.620 |
Why?
|
| Diabetes Mellitus, Type 1 | 10 | 2011 | 562 | 0.470 |
Why?
|
| Patient-Centered Care | 2 | 2011 | 207 | 0.410 |
Why?
|
| Attitude of Health Personnel | 6 | 2008 | 642 | 0.400 |
Why?
|
| Group Practice | 1 | 2011 | 7 | 0.400 |
Why?
|
| Health Facility Size | 1 | 2011 | 9 | 0.390 |
Why?
|
| Health Status | 3 | 2009 | 370 | 0.350 |
Why?
|
| Body Mass Index | 2 | 2014 | 770 | 0.350 |
Why?
|
| Health Services Accessibility | 3 | 2010 | 419 | 0.340 |
Why?
|
| Oxycodone | 1 | 2009 | 35 | 0.340 |
Why?
|
| Psychomotor Performance | 2 | 2009 | 497 | 0.340 |
Why?
|
| Puberty, Precocious | 1 | 2009 | 36 | 0.330 |
Why?
|
| Menarche | 1 | 2009 | 29 | 0.330 |
Why?
|
| Puberty | 1 | 2009 | 60 | 0.320 |
Why?
|
| Sex Characteristics | 3 | 2009 | 321 | 0.320 |
Why?
|
| Health Surveys | 1 | 2009 | 239 | 0.310 |
Why?
|
| Overweight | 1 | 2009 | 118 | 0.300 |
Why?
|
| Ethanol | 1 | 2009 | 250 | 0.290 |
Why?
|
| Alcoholism | 1 | 2009 | 179 | 0.290 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 299 | 0.290 |
Why?
|
| Aging | 2 | 2009 | 712 | 0.290 |
Why?
|
| Patient Satisfaction | 3 | 2011 | 461 | 0.280 |
Why?
|
| Social Behavior | 1 | 2009 | 298 | 0.270 |
Why?
|
| Smoking | 2 | 2009 | 618 | 0.260 |
Why?
|
| Analgesics, Opioid | 1 | 2009 | 438 | 0.250 |
Why?
|
| Cardiopulmonary Bypass | 5 | 2010 | 158 | 0.250 |
Why?
|
| Healthcare Disparities | 4 | 2011 | 399 | 0.240 |
Why?
|
| Physician-Patient Relations | 2 | 2011 | 622 | 0.240 |
Why?
|
| Empathy | 1 | 2005 | 150 | 0.220 |
Why?
|
| Male | 40 | 2014 | 42059 | 0.210 |
Why?
|
| General Surgery | 1 | 2005 | 235 | 0.210 |
Why?
|
| Cross-Sectional Studies | 8 | 2011 | 1694 | 0.210 |
Why?
|
| Female | 40 | 2014 | 45812 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2011 | 1171 | 0.170 |
Why?
|
| Obesity | 4 | 2013 | 973 | 0.170 |
Why?
|
| Medically Uninsured | 2 | 2010 | 60 | 0.170 |
Why?
|
| Adult | 26 | 2011 | 26383 | 0.170 |
Why?
|
| Humans | 51 | 2014 | 88694 | 0.170 |
Why?
|
| Middle Aged | 28 | 2011 | 25742 | 0.160 |
Why?
|
| Logistic Models | 9 | 2011 | 1207 | 0.160 |
Why?
|
| Sex Factors | 4 | 2009 | 1064 | 0.160 |
Why?
|
| Adolescent | 16 | 2014 | 9170 | 0.150 |
Why?
|
| Child | 13 | 2014 | 7094 | 0.140 |
Why?
|
| Aged | 19 | 2011 | 18970 | 0.140 |
Why?
|
| Patient Care Management | 2 | 2007 | 31 | 0.140 |
Why?
|
| Surveys and Questionnaires | 7 | 2011 | 2598 | 0.140 |
Why?
|
| Anesthesia | 2 | 2010 | 169 | 0.130 |
Why?
|
| United States | 10 | 2011 | 6898 | 0.130 |
Why?
|
| Substance-Related Disorders | 3 | 2009 | 413 | 0.130 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2009 | 473 | 0.120 |
Why?
|
| Socioeconomic Factors | 8 | 2008 | 579 | 0.120 |
Why?
|
| Mothers | 1 | 2014 | 142 | 0.110 |
Why?
|
| Aged, 80 and over | 8 | 2011 | 6740 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 3 | 2008 | 225 | 0.100 |
Why?
|
| Nutrition Surveys | 2 | 2011 | 112 | 0.100 |
Why?
|
| Nausea | 2 | 2011 | 176 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 1945 | 0.100 |
Why?
|
| Community Health Services | 1 | 2013 | 82 | 0.100 |
Why?
|
| Oxygen | 2 | 2010 | 743 | 0.100 |
Why?
|
| Dobutamine | 2 | 2002 | 61 | 0.100 |
Why?
|
| Morale | 2 | 2008 | 14 | 0.100 |
Why?
|
| Bupivacaine | 1 | 2011 | 45 | 0.100 |
Why?
|
| Arthralgia | 1 | 2011 | 38 | 0.100 |
Why?
|
| Nerve Block | 1 | 2011 | 50 | 0.100 |
Why?
|
| Patient Education as Topic | 4 | 2007 | 357 | 0.100 |
Why?
|
| Midwestern United States | 5 | 2013 | 82 | 0.100 |
Why?
|
| HLA-DQ Antigens | 1 | 2011 | 51 | 0.090 |
Why?
|
| Hawaii | 1 | 2010 | 25 | 0.090 |
Why?
|
| Translating | 1 | 2010 | 18 | 0.090 |
Why?
|
| New York City | 1 | 2010 | 61 | 0.090 |
Why?
|
| Washington | 1 | 2010 | 49 | 0.090 |
Why?
|
| Prejudice | 1 | 2011 | 48 | 0.090 |
Why?
|
| Insurance Coverage | 2 | 2008 | 119 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2010 | 36 | 0.090 |
Why?
|
| Insurance, Health | 2 | 2008 | 160 | 0.090 |
Why?
|
| Reproducibility of Results | 4 | 2011 | 2746 | 0.090 |
Why?
|
| Coronary Artery Bypass | 2 | 2002 | 235 | 0.090 |
Why?
|
| Primary Health Care | 2 | 2011 | 350 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 111 | 0.090 |
Why?
|
| Chicago | 7 | 2011 | 1411 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 2 | 2008 | 146 | 0.090 |
Why?
|
| Insulin Resistance | 2 | 2009 | 365 | 0.090 |
Why?
|
| Educational Status | 3 | 2007 | 191 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2011 | 334 | 0.090 |
Why?
|
| Anesthetics | 1 | 2010 | 53 | 0.090 |
Why?
|
| Aprotinin | 1 | 2009 | 26 | 0.090 |
Why?
|
| Plasma | 1 | 2009 | 51 | 0.090 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2009 | 10 | 0.090 |
Why?
|
| Psychopharmacology | 1 | 2009 | 26 | 0.090 |
Why?
|
| Electromyography | 1 | 2010 | 193 | 0.090 |
Why?
|
| Sleep Deprivation | 1 | 2011 | 137 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2011 | 115 | 0.090 |
Why?
|
| Burnout, Professional | 2 | 2008 | 99 | 0.090 |
Why?
|
| Bandages | 1 | 2009 | 41 | 0.090 |
Why?
|
| Lidocaine | 1 | 2009 | 64 | 0.080 |
Why?
|
| Prevalence | 6 | 2011 | 1252 | 0.080 |
Why?
|
| Age Factors | 4 | 2009 | 1865 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2009 | 248 | 0.080 |
Why?
|
| Cotinine | 1 | 2009 | 12 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2011 | 250 | 0.080 |
Why?
|
| Vision Disorders | 1 | 2009 | 75 | 0.080 |
Why?
|
| Erythrocyte Transfusion | 1 | 2009 | 72 | 0.080 |
Why?
|
| Anesthetics, Local | 1 | 2009 | 76 | 0.080 |
Why?
|
| Family | 1 | 2011 | 324 | 0.080 |
Why?
|
| Total Quality Management | 1 | 2008 | 33 | 0.080 |
Why?
|
| Health Behavior | 2 | 2008 | 183 | 0.080 |
Why?
|
| Body Composition | 1 | 2009 | 70 | 0.080 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2008 | 20 | 0.080 |
Why?
|
| Alphapapillomavirus | 1 | 2008 | 45 | 0.080 |
Why?
|
| Health Facility Administrators | 1 | 2008 | 15 | 0.080 |
Why?
|
| Personnel Management | 1 | 2008 | 7 | 0.080 |
Why?
|
| Methyl Ethers | 1 | 2008 | 33 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 124 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2009 | 255 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2009 | 329 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 128 | 0.080 |
Why?
|
| Sexual Behavior | 1 | 2010 | 308 | 0.070 |
Why?
|
| Child, Preschool | 6 | 2014 | 3680 | 0.070 |
Why?
|
| Body Weight | 1 | 2009 | 455 | 0.070 |
Why?
|
| Professional Role | 1 | 2007 | 41 | 0.070 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 98 | 0.070 |
Why?
|
| Program Development | 1 | 2007 | 123 | 0.070 |
Why?
|
| Income | 2 | 2005 | 81 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 140 | 0.070 |
Why?
|
| beta Carotene | 2 | 1997 | 4 | 0.070 |
Why?
|
| Leadership | 1 | 2008 | 136 | 0.070 |
Why?
|
| Ascorbic Acid | 2 | 1997 | 38 | 0.070 |
Why?
|
| Pain | 1 | 2009 | 401 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2008 | 160 | 0.070 |
Why?
|
| Testosterone | 1 | 2008 | 275 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2007 | 303 | 0.070 |
Why?
|
| Echocardiography | 2 | 2002 | 935 | 0.070 |
Why?
|
| Domestic Violence | 1 | 2006 | 24 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2009 | 250 | 0.070 |
Why?
|
| Frustration | 1 | 2005 | 4 | 0.070 |
Why?
|
| Diet | 3 | 2001 | 442 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2007 | 525 | 0.070 |
Why?
|
| Oregon | 1 | 2005 | 26 | 0.070 |
Why?
|
| Colorado | 1 | 2005 | 37 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2009 | 350 | 0.060 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 93 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2008 | 260 | 0.060 |
Why?
|
| Self-Assessment | 1 | 2005 | 47 | 0.060 |
Why?
|
| Tidal Volume | 1 | 2005 | 54 | 0.060 |
Why?
|
| Office Visits | 1 | 2005 | 50 | 0.060 |
Why?
|
| Professional Competence | 1 | 2005 | 69 | 0.060 |
Why?
|
| Mass Screening | 2 | 2007 | 632 | 0.060 |
Why?
|
| Ventilators, Mechanical | 1 | 2005 | 37 | 0.060 |
Why?
|
| Respiration, Artificial | 2 | 2005 | 350 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2008 | 384 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 995 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 102 | 0.060 |
Why?
|
| Social Class | 1 | 2003 | 134 | 0.050 |
Why?
|
| Health Care Surveys | 3 | 2009 | 281 | 0.050 |
Why?
|
| Diabetes Complications | 3 | 2008 | 172 | 0.050 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2002 | 72 | 0.050 |
Why?
|
| Risk Factors | 6 | 2009 | 5456 | 0.050 |
Why?
|
| Self Care | 1 | 2003 | 164 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2002 | 58 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2002 | 72 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 510 | 0.050 |
Why?
|
| Albumins | 1 | 2002 | 130 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2001 | 36 | 0.050 |
Why?
|
| Critical Care | 1 | 2005 | 379 | 0.050 |
Why?
|
| Vasodilation | 1 | 2001 | 94 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 2 | 2011 | 32 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 146 | 0.050 |
Why?
|
| Comorbidity | 3 | 2009 | 947 | 0.050 |
Why?
|
| Registries | 4 | 2007 | 760 | 0.050 |
Why?
|
| Young Adult | 5 | 2011 | 6232 | 0.050 |
Why?
|
| Physicians | 1 | 2008 | 684 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2001 | 217 | 0.040 |
Why?
|
| Hypertension | 1 | 2006 | 733 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2002 | 346 | 0.040 |
Why?
|
| Sexual Harassment | 1 | 1999 | 9 | 0.040 |
Why?
|
| Workplace | 1 | 1999 | 29 | 0.040 |
Why?
|
| Occupational Health | 1 | 1999 | 34 | 0.040 |
Why?
|
| Drug Utilization | 2 | 2009 | 65 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2014 | 841 | 0.040 |
Why?
|
| Universities | 1 | 1999 | 146 | 0.040 |
Why?
|
| Mental Health | 1 | 1999 | 175 | 0.040 |
Why?
|
| Heart | 1 | 2000 | 572 | 0.040 |
Why?
|
| Age of Onset | 2 | 2008 | 312 | 0.040 |
Why?
|
| Professional-Patient Relations | 2 | 2007 | 53 | 0.040 |
Why?
|
| Contrast Media | 1 | 2002 | 1088 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2002 | 779 | 0.040 |
Why?
|
| Illinois | 3 | 2009 | 465 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2010 | 4272 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2011 | 1716 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1996 | 72 | 0.030 |
Why?
|
| Health Status Disparities | 2 | 2008 | 183 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2009 | 686 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 143 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1054 | 0.030 |
Why?
|
| Environmental Pollutants | 1 | 1996 | 51 | 0.030 |
Why?
|
| Guideline Adherence | 2 | 2008 | 227 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2010 | 1542 | 0.030 |
Why?
|
| Water Pollutants, Chemical | 1 | 1996 | 135 | 0.030 |
Why?
|
| Fishes | 1 | 1996 | 137 | 0.030 |
Why?
|
| Urban Population | 2 | 2008 | 223 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2009 | 2290 | 0.030 |
Why?
|
| Incidence | 3 | 2007 | 1593 | 0.030 |
Why?
|
| Phenotype | 2 | 2011 | 2435 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2007 | 575 | 0.030 |
Why?
|
| Intraoperative Period | 2 | 2002 | 90 | 0.030 |
Why?
|
| Premedication | 1 | 2011 | 57 | 0.020 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 2011 | 16 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 66 | 0.020 |
Why?
|
| C-Peptide | 1 | 2011 | 179 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2011 | 113 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2007 | 2837 | 0.020 |
Why?
|
| Hematocrit | 1 | 2010 | 68 | 0.020 |
Why?
|
| Pregnancy | 2 | 2014 | 2997 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2013 | 774 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2009 | 8903 | 0.020 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2009 | 7 | 0.020 |
Why?
|
| Body Temperature | 1 | 2010 | 125 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 5320 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 867 | 0.020 |
Why?
|
| Blindness, Cortical | 1 | 2009 | 8 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2011 | 268 | 0.020 |
Why?
|
| Transfusion Reaction | 1 | 2009 | 17 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2010 | 110 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2009 | 93 | 0.020 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2009 | 19 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2009 | 55 | 0.020 |
Why?
|
| Psychometrics | 1 | 2011 | 329 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2009 | 115 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2009 | 84 | 0.020 |
Why?
|
| Time Management | 1 | 2008 | 9 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 637 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2013 | 444 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 227 | 0.020 |
Why?
|
| Anemia | 1 | 2009 | 126 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 2009 | 90 | 0.020 |
Why?
|
| Employee Incentive Plans | 1 | 2008 | 4 | 0.020 |
Why?
|
| Personnel Loyalty | 1 | 2008 | 4 | 0.020 |
Why?
|
| Resource Allocation | 1 | 2008 | 65 | 0.020 |
Why?
|
| Professional Autonomy | 1 | 2008 | 41 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2007 | 11 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2008 | 80 | 0.020 |
Why?
|
| Health Services Research | 1 | 2008 | 137 | 0.020 |
Why?
|
| Helping Behavior | 1 | 2007 | 8 | 0.020 |
Why?
|
| Staff Development | 1 | 2008 | 26 | 0.020 |
Why?
|
| Medical Staff | 1 | 2007 | 10 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2007 | 20 | 0.020 |
Why?
|
| Nursing Staff | 1 | 2007 | 10 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2008 | 87 | 0.020 |
Why?
|
| Specialization | 1 | 2008 | 65 | 0.020 |
Why?
|
| Population Groups | 1 | 2007 | 42 | 0.020 |
Why?
|
| Siblings | 1 | 2008 | 111 | 0.020 |
Why?
|
| Nurse Practitioners | 1 | 2007 | 31 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2008 | 75 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 403 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 186 | 0.020 |
Why?
|
| Medicine | 1 | 2008 | 90 | 0.020 |
Why?
|
| Reoperation | 1 | 2009 | 605 | 0.020 |
Why?
|
| Hospitals | 1 | 2009 | 298 | 0.020 |
Why?
|
| Workload | 1 | 2008 | 129 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 665 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2007 | 103 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2007 | 179 | 0.020 |
Why?
|
| Computers | 1 | 2006 | 112 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 351 | 0.020 |
Why?
|
| Motivation | 1 | 2008 | 295 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2010 | 745 | 0.020 |
Why?
|
| Infant | 2 | 2005 | 3121 | 0.020 |
Why?
|
| Patient Participation | 1 | 2007 | 224 | 0.020 |
Why?
|
| Air Pressure | 1 | 2005 | 7 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 456 | 0.020 |
Why?
|
| Life Style | 1 | 2006 | 172 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 1764 | 0.020 |
Why?
|
| Biomarkers | 1 | 2011 | 1756 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 948 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2004 | 47 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 1867 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 594 | 0.010 |
Why?
|
| Insulin | 1 | 2008 | 1155 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 902 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 360 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 108 | 0.010 |
Why?
|
| Blood Circulation | 1 | 2001 | 30 | 0.010 |
Why?
|
| Diabetic Foot | 1 | 2001 | 14 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 161 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2002 | 202 | 0.010 |
Why?
|
| Anesthesia, General | 1 | 2002 | 116 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 1042 | 0.010 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2001 | 54 | 0.010 |
Why?
|
| Observer Variation | 1 | 2001 | 609 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 2001 | 91 | 0.010 |
Why?
|
| Cohort Effect | 1 | 1999 | 6 | 0.010 |
Why?
|
| Occupations | 1 | 1999 | 25 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 1999 | 48 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2001 | 235 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1999 | 172 | 0.010 |
Why?
|
| Housing | 1 | 1999 | 45 | 0.010 |
Why?
|
| Exercise | 1 | 2001 | 322 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1709 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 8187 | 0.010 |
Why?
|
| Dieldrin | 1 | 1996 | 1 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1997 | 84 | 0.010 |
Why?
|
| Great Lakes Region | 1 | 1996 | 2 | 0.010 |
Why?
|
| Body Burden | 1 | 1996 | 9 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1996 | 28 | 0.010 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 1996 | 6 | 0.010 |
Why?
|
| Fresh Water | 1 | 1996 | 20 | 0.010 |
Why?
|
| Polychlorinated Biphenyls | 1 | 1996 | 7 | 0.010 |
Why?
|
| Food Contamination | 1 | 1996 | 32 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1999 | 321 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 1996 | 133 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 3658 | 0.010 |
Why?
|
| Risk | 1 | 1997 | 660 | 0.010 |
Why?
|
| Data Collection | 1 | 1996 | 374 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 3753 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 859 | 0.010 |
Why?
|
| Animals | 1 | 1996 | 27238 | 0.000 |
Why?
|